Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
about
The Gut Microbiota in Immune-Mediated Inflammatory DiseasesGlucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implicationsCombined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility lociIKKβ in intestinal epithelial cells regulates allergen-specific IgA and allergic inflammation at distant mucosal sites.The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population.Environmental risk factors in multiple sclerosis.A functional variant in ERAP1 predisposes to multiple sclerosis.Inflammatory bowel disease and asthma: a population-based, case-control studyMapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytesImmune-related disorders in families of children with inflammatory bowel disease--a prospective cohort study.Exome analysis of patients with concurrent pediatric inflammatory bowel disease and autoimmune disease.Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.A De Novo Arisen Case of Primary Adrenal Insufficiency in an Adolescent Patient With Crohn Disease: A Case report.Asthma and proinflammatory conditions: a population-based retrospective matched cohort study.Parental inflammatory bowel disease and risk of asthma in offspring: a nationwide cohort study in denmark.A two-marker haplotype in the IRF5 gene is associated with inflammatory bowel disease in a North American cohort.Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseasesSecondary pouchitis: those with identifiable etiopathogenetic or triggering factors.Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.Gender issues in multiple sclerosis: an update.Inflammatory bowel disease: beyond the boundaries of the bowel.The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.Adalimumab in the treatment of immune-mediated diseases.The role of interleukin-17A in psoriatic disease.Asthma in the older adult: presentation, considerations and clinical management.Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study.Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation.Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics.Clinical trials in dermatology.Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.The history of genetics in inflammatory bowel disease.Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinician.Familial association of inflammatory bowel diseases with other autoimmune and related diseases.The burden of comedication among patients with inflammatory bowel disease.Identification of a new disease cluster of pemphigus vulgaris with autoimmune thyroid disease, rheumatoid arthritis and type I diabetes.IRF5, but not TLR4, DEFB1, or VDR, is associated with the risk of ulcerative colitis in a Han Chinese population.The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.
P2860
Q26741414-74B362D8-A3D7-4CBD-A920-1CD063C641F8Q26866110-433E81F0-4095-48FC-BE9D-A5F7A0C3D417Q28924378-2C11E421-713E-47F1-A39F-49F64B47B6C3Q33741141-1E9BD6AC-E69A-4B0C-97E5-852EE7DCB839Q33964509-FF96164E-1D01-41FA-AB3D-C4BDA8AF8460Q34100847-37EDDE67-EFF6-4620-9C96-1CDF49C3AEC5Q34130800-2922EDCF-7189-477E-9905-99EEEDE87DFEQ34222244-82B71621-DA99-4285-BD0D-B99DC78C85EBQ34275669-1A58A563-A9BD-4553-B3DB-CF54A04E77DBQ35397148-A7C54DE9-BA92-4215-AFE2-58E3D3B8BE0FQ35670620-7AB3687D-10B2-498C-9D28-74B6E8BB30B3Q36174814-93F43508-AE00-436A-845B-6E5A25A8C8EFQ36194145-AFD54069-1E04-4278-AAD5-37DA07FC5A12Q36512847-903BDEC8-9F82-4661-A829-D0BDBF68D441Q37137468-F9066B41-37CF-49A0-BDC4-0EF6CABAA158Q37259906-9575AD3D-3558-4721-8179-70E76C126BB3Q37438934-09455749-3A16-48BC-99E0-35D91D3518B0Q37597879-FEE196A9-467C-4632-88D5-48E592B07F06Q37781314-D79130E6-0E35-4C92-93EE-A7478D7A606CQ37813691-BF601E7E-3E3A-46D1-B470-30DE54266C0DQ37886164-230888AA-AAB9-4CE7-A073-6CD413C85041Q38207758-FE5DBE47-1B6C-4D35-AC48-4D794CA73676Q38207760-895E4D2E-C33F-40BC-8F6F-3BDFD000740BQ38217029-683D9F76-C499-47E5-822D-BA1B3F092DADQ38584352-F47FA3F9-5D75-4944-8A43-DFCA182CF2BBQ39559169-CE90A5CF-A06A-4B64-BE92-12BE26792A89Q39993268-0E38EA43-E727-4661-9786-96C8460C073FQ40058815-9A439B51-68E6-4687-A0A8-54CE350FF975Q41060904-C567BAFF-1CB1-4C87-9DF8-B80142E26964Q41378761-89F779DE-6ED9-4454-9072-B3AC992DF67CQ42127776-A2F364D0-E3F6-4BA6-ACAE-6B910E565E47Q42689162-F4DCB5E6-DF5B-464F-B73F-9E5794FE0E27Q43892254-94067675-15BF-4803-9EAA-2149AEFD4F06Q44195758-5FCD2CC8-D1BC-4A1C-A0B8-29F156BD3DFCQ44569591-02E7725A-93B8-45D9-9DA0-D48F5CF516C3Q44995617-4B799634-CB7F-434C-8BEC-2FB2DABD6DCEQ46077604-1D2E05DF-AEC9-4CF0-B32A-A48744045D6EQ47716201-AA72AD02-A8EE-4837-B4B4-A93712EE1780Q48331765-538F7C95-9889-4009-9441-DC4ED650662DQ49917457-51059EFD-C1F4-4C37-91AC-53B81A20AB2F
P2860
Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Clustering of inflammatory bow ...... nia-managed care organization.
@en
Clustering of inflammatory bow ...... nia-managed care organization.
@nl
type
label
Clustering of inflammatory bow ...... nia-managed care organization.
@en
Clustering of inflammatory bow ...... nia-managed care organization.
@nl
prefLabel
Clustering of inflammatory bow ...... nia-managed care organization.
@en
Clustering of inflammatory bow ...... nia-managed care organization.
@nl
P2093
P2860
P1476
Clustering of inflammatory bow ...... nia-managed care organization.
@en
P2093
James E Allison
Lisa F Barcellos
Lisa J Herrinton
Xiaoping Weng
P2860
P304
P356
10.1111/J.1572-0241.2007.01215.X
P407
P577
2007-04-16T00:00:00Z